AusBN – Crescent Capital Partners has acquired Healthscope’s Australian pathology operations for A$105 million.
Over 500 collection centres and 30 laboratories in Victoria and the Northern Territory will now be operated by Crescent Capital.
Healthscope will also transfer six of its skin clinics to Crescent and the proceeds from the sale will be used to fund its expansion plans at major hospital sites.
Healthscope CEO Robert Cooke said: “Our Australian pathology operations are non-core, have been operating in challenging market conditions for a number of years and their underlying earnings contribution to the group is limited.
“We remain committed to our international pathology operations, which have consistently performed well over time.”